logo

Aslan Pharmaceuticals (ASLN)



Trade ASLN now with
  Date
  Headline
9/14/2022 7:17:36 AM ASLAN Pharma Begins Clinical Program To Study Eblasakimab In Dupilumab-Experienced Atopic Dermatitis Patients
8/25/2022 7:21:00 AM ASLAN Licenses BelleStudy Digital Image Capture Software In Support Of ASLAN's Clinical Trials For Atopic Dermatitis
10/26/2021 8:01:12 AM ASLAN Pharma Q3 Net Loss $8.6 Mln Vs Loss Of $3.5 Mln Last Year